Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2014
05/06/2014US8716494 Pyrrolidinone carboxamide derivatives
05/06/2014US8716493 Multicyclic compounds and the use thereof
05/06/2014US8716492 Five-membered heterocycles useful as serine protease inhibitors
05/06/2014US8716490 Compound having detrusor muscle-contracting activity and urethral sphincter muscle-relaxing activity
05/06/2014US8716486 2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases
05/06/2014US8716483 Compounds that are ERK inhibitors
05/06/2014US8716482 Substituted aminopiperidines as dipeptidyl peptidase-IV inhibitors for the treatment of diabetes
05/06/2014US8716478 Boron-containing small molecules
05/06/2014US8716475 2-aminopyrimidine modulators of the histamine H4 receptor
05/06/2014US8716473 Substituted benzotriazines and quinoxalines as inhibitors of P7OS6 kinase
05/06/2014US8716471 Process for the preparation of tetrazine derivatives
05/06/2014US8716470 Guanidine compound
05/06/2014US8716469 Synthetic oligosaccharides for Moraxella vaccine
05/06/2014US8716447 Optically-based stimulation of target cells and modifications thereto
05/06/2014US8716363 Biodegradable putty compositions and implant devices, methods, and kits relating to the same
05/06/2014US8716355 Hydroxylated tolans and related compounds in the treatment of a cancer
05/06/2014US8716354 Propofol compositions and methods for reducing pain associated with propofol injection
05/06/2014US8716353 Methods of treating gastrointestinal spasms in a subject having Crohn's Disease or ulcerative colitis
05/06/2014US8716352 Tannin formulation for treating GI spasms
05/06/2014US8716351 Methods of treating gastrointestinal spasms
05/06/2014US8716350 Compositions and methods for the treatment of somatosensory disorders
05/06/2014US8716349 Compositions and methods for the treatment of somatosensory disorders
05/06/2014US8716348 Formoterol/steroid bronchodilating compositions and methods of use thereof
05/06/2014US8716347 Tramadol for the treatment of functional gastrointestinal disorders
05/06/2014US8716346 Alkylating agent combinations in the treatment of cancer
05/06/2014US8716345 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
05/06/2014US8716344 Class- and isoform-specific HDAC inhibitors and uses thereof
05/06/2014US8716343 Calixarene-based peptide conformation mimetics, methods of use, and methods of making
05/06/2014US8716342 Method for preparing molecular complexes between adapalene and cyclodextrins
05/06/2014US8716341 Topically applicable compositions for the treatment of keratinization disorders
05/06/2014US8716340 Topical composition
05/06/2014US8716339 Two-part disinfectant system and related methods
05/06/2014US8716338 Dosage units of 3-(6-(1-(2,2-difluorobenzo[D] [1,3] dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
05/06/2014US8716337 Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder
05/06/2014US8716336 Smooth-feeling wax-based compositions for personal care preparations
05/06/2014US8716335 Substituted benzofurans, benzothiophenes, benzoselenophenes and indoles and their use as tubulin polymerisation inhibitors
05/06/2014US8716334 Substituted cyclohexylidene-ethylidene-octahydro-indene compounds
05/06/2014US8716333 Process and compounds for the manufacture of oseltamivir and analogs thereof, and new antiviral agents
05/06/2014US8716332 Supplement composition and method of use to treat anhidrosis
05/06/2014US8716331 Supplement composition and methods of use
05/06/2014US8716330 Supplement composition and method of use
05/06/2014US8716329 Use of parthenolide derivatives as antileukemic and cytotoxic agents
05/06/2014US8716327 Methods of treating fatty liver disease
05/06/2014US8716326 Isoindolinone derivatives, preparation method thereof and a pharmaceutical composition comprising same
05/06/2014US8716325 Treatment of cachexia
05/06/2014US8716324 Tricyclic indeno-pyrrole derivatives as serotonin receptor modulators
05/06/2014US8716323 Cyclic protein tyrosine kinase inhibitors
05/06/2014US8716322 Compounds for enzyme inhibition
05/06/2014US8716321 Methods for dosing an orally active 1,2,4-oxadiazole
05/06/2014US8716320 Antibacteriall heterocyclic ureas
05/06/2014US8716319 Substituted heterocyclic compounds
05/06/2014US8716318 Pyridone sulfonamides and pyridone sulfamides as MEK inhibitors
05/06/2014US8716317 Sulfonamides with heterocycle and oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals
05/06/2014US8716316 Positive allosteric modulators (PAM)
05/06/2014US8716315 Analogs of thalidomide as potential angiogenesis inhibitors
05/06/2014US8716314 Isotopologues of thalidomide
05/06/2014US8716313 Crystalline forms of a biphenyl compound
05/06/2014US8716312 Inhibitors of diacylglycerol acyltransferase
05/06/2014US8716311 Use of piperidine ester derivative as solvent in cosmetic compositions; cosmetic compositions comprising it
05/06/2014US8716310 Dual mechanism inhibitors for the treatment of disease
05/06/2014US8716309 Pharmaceutical composition comprising pyridone derivatives
05/06/2014US8716308 (1-azinone)-substituted pyridoindoles
05/06/2014US8716307 Combination antineoplastic therapy
05/06/2014US8716306 Carboxamide bioisosteres of opiates
05/06/2014US8716305 Multicomponent crystalline system of rosuvastatin calcium salt and vanillin
05/06/2014US8716304 Preparation method of MLN4924 as an E1 activating inhibitor
05/06/2014US8716303 N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
05/06/2014US8716302 Compounds for inducing cellular apoptosis
05/06/2014US8716301 Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation
05/06/2014US8716300 Frequency modulated drug delivery (FMDD)
05/06/2014US8716299 XIAP-targeted prostate cancer therapy
05/06/2014US8716298 Composition for reducing skin wrinkles including PDE5 inhibitor
05/06/2014US8716297 Chemical entities to be used for Wee1 inhibition for the treatment of cancer
05/06/2014US8716295 Fluoroquinolone derivatives or sulfonamide moiety-containing compounds as inhibitors of tyrosyl-dnaphosphodiesterase (TDP1)
05/06/2014US8716294 Methods for treating inflammatory conditions
05/06/2014US8716293 Macrocyclic integrase inhibitors
05/06/2014US8716292 Riminophenazines with 2-(heteroaryl)amino substituents and their anti-microbial activity
05/06/2014US8716291 Certain 1H-imidazo[4,5-b]pyrazin-2(3H)-ones and 1H-imidazo[4,5-b]pyrazin-2-ols and methods for their use
05/06/2014US8716290 Heterocyclic compounds and their uses
05/06/2014US8716289 Carbamate derivatives of alkyl-heterocycles, preparation thereof and therapeutic use thereof
05/06/2014US8716288 Composition comprising benproperine derivatives as active ingredients for preventing and treating angiogenesis-related diseases
05/06/2014US8716287 Pharmaceutical compounds
05/06/2014US8716286 Crystalline forms of (3R, 6R)-3-(2,3-dihydro-1H-inden-2-yl)-1-[(1R)-1-(2,6-dimethyl-3-pyridinyl)-2-(4-morpholinyl)-2-oxoethyl]-6-[(1S)-1-methylpropyl]-2,5-piperazinedione
05/06/2014US8716285 N-hydroxy-benzamids for the treatment of cancer
05/06/2014US8716284 Adamantyl diamide derivatives and uses of same
05/06/2014US8716283 Type III secretion inhibitors, analogs and uses thereof
05/06/2014US8716282 Imidazo[1,2-b]pyridazine derivatives and their use as PDE10 inhibitors
05/06/2014US8716281 Pyrimidine compounds that inhibit anaplastic lymphoma kinase
05/06/2014US8716280 Bicyclic antibiotics
05/06/2014US8716278 Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder
05/06/2014US8716277 Substituted imidazole compounds useful as positive allosteric modulators of mGlu5 receptor activity
05/06/2014US8716276 Thiophenyl and pyrrolyl azepines as serotonin 5-HT2C receptor ligands and uses thereof
05/06/2014US8716275 Compound for the treatment of hepatitis C
05/06/2014US8716274 Heteroaryl pyridone and aza-pyridone compounds
05/06/2014US8716273 N-(amino-heteroaryl)-1H-pyrrolopyridine-2-carboxamides derivatives preparation thereof and their use in therapy
05/06/2014US8716272 N-(amino-heteroaryI)-1H-pyrrolopyridine-2-carboxamides derivatives preparation thereof and their use in therapy
05/06/2014US8716271 Therapeutic compositions
05/06/2014US8716270 Polymorphic and amorphous salt forms of squalamine dilactate
05/06/2014US8716269 Combination of pilocarpin and methimazol for treating Charcot-Marietooth disease and related disorders
05/06/2014US8716268 Nitrate esters of corticoid compounds useful as diuretics
1 ... 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 ... 7860